Fresh attention on Charles Schwab (SCHW) comes after Linqto’s ongoing litigation against Forge Global and Schwab, as well as Schwab’s recent multibillion-dollar fixed income offerings, prompting investors to reassess the stock’s risk profile and funding mix.
See our latest analysis for Charles Schwab.
At a share price of $111.68, Charles Schwab has seen a 23.94% 90 day share price return and an 18.12% 1 year total shareholder return. This suggests momentum has been building as investors weigh the Linqto litigation alongside fresh fixed income issuance and product launches in futures and long short strategies.
If this kind of activity has you thinking more broadly about where capital is moving, it can be worth scanning other areas of the market through our 21 top founder-led companies
Charles Schwab now trades about 12% below both analyst targets and an estimated fair value, even after a strong run. Is that a simple valuation gap, or is the market applying a justified discount for litigation and funding risks?
The most followed narrative pegs Charles Schwab’s fair value at about $101, below the recent $111.68 share price, and builds that view around detailed revenue, margin and risk assumptions.
Heavy investment in AI, technology and new platforms such as spot crypto could overshoot sustainable demand. This may lead to structurally higher run-rate technology and personnel spending that compresses operating leverage and erodes pretax margins, even if revenues keep growing.
Want to see why this narrative still expects higher earnings yet lands on a lower fair value? The story blends rising revenue, shifting margins and a trimmed future earnings multiple into one tight valuation case.
Result: Fair Value of $101.12 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the narrative could still be challenged if younger, highly engaged clients keep building long term relationships with Charles Schwab and if higher value advisory flows continue to grow.
Find out about the key risks to this Charles Schwab narrative.
The first narrative leans on analyst targets and long term earnings assumptions, and lands on Charles Schwab looking about 10% overvalued at a fair value of roughly $101 per share. Using our DCF model tells a different story. On that measure, the stock screens as undervalued at around $126.90. Which framework do you think better reflects how Schwab’s cash flows might evolve over time?
Look into how the SWS DCF model arrives at its fair value.
With mixed sentiment around Charles Schwab’s valuation, litigation exposure and funding choices, now is a good time to review the underlying data yourself and decide what matters most. To balance the concerns against the potential upside, start with the 4 key rewards and 1 important warning sign.
If you want a broader view of where your next opportunity might come from, use the Simply Wall St screener to compare Charles Schwab with other potential candidates.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com